PRQR | tickerfilter.com

Fundamental analysis

24%

Profitability 25%

Dept financing 5%

Liquidity 50%

Performance 21%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-5.61%

1 Month

8.60%

3 Months

10.38%

6 Months

1.00%

1 Year

27.04%

2 Year

161.25%

Key data

Stock price

$2.04

P/E Ratio

0.00

DAY RANGE

$1.98 - N/A

EPS

$0.00

52 WEEK RANGE

$1.11 - $3.29

52 WEEK CHANGE

$0.27

MARKET CAP

164.336 M

YIELD

N/A

SHARES OUTSTANDING

81.355 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/14/2024

BETA

0.37

PUBLIC FLOAT

AVERAGE 10 VOLUME

$109,254

AVERAGE 30 VOLUME

$156,881

Company detail

CEO: Daniel De Boer
Region: US
Website: https://www.proqr.com/
Employees: 150
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

proqr therapeutics is a leiden, nl based biotech company focused on developments of drugs to treat genetic disorders. based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. founded by industry icons and based on ground breaking science we strive to make a meaningful impact. check out our website for vacancies: www.proqr.com

PRQR - ProQR Therapeutics N.V